跳至主要内容
临床试验/JPRN-UMIN000003141
JPRN-UMIN000003141招募中2 期

A randomised phase II trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in second-line treatment of advaneced or recurrent gastric cancer resistant to Docetaxel/Cisplatin/TS-1 (DCS) therapy - A randomized phase II study of CPT-11/CDDP versus CPT-11 in second-line treatment of advanced/recurrent gastric cancer after DCS chemotherapy

Sapporo Medical University School of Medicine Dept. of Internal Medicine(4)0 个研究点目标入组 80 人开始时间: 2010年2月6日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) With uncontrolled pleural effusion or ascites. (2) Active concomitant malignancy. (3) With infectious disease which needs treatment. (4) Uncontrolled medical conditions (e.g., congestive heart failure, ileus, interstitial pneumonia, pulmonary fibrosis, diabetes, interstitial pneumonia, pulmonary fibrosis, renal failure). (5) Watery stool (diarrhea). (6) With a history of mental disorder. (7) Pregnant or lactating women and women of child bearing potential not using contraception. (8) Drug hypersensitivity or severe drug allergy. (9) Inappropriate recruit to the study judged by an investigator in charge.

研究者

发起方
Sapporo Medical University School of Medicine Dept. of Internal Medicine(4)

相似试验